Cabaletta Bio Inc CABA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:18 AM EDT
12.30quote price arrow down-0.11 (-0.89%)
Volume
229,931
52 week range
9.02 - 26.35
Loading...
  • Open12.51
  • Day High13.10
  • Day Low12.18
  • Prev Close12.41
  • 52 Week High26.35
  • 52 Week High Date02/08/24
  • 52 Week Low9.02
  • 52 Week Low Date05/30/23

Key Stats

  • Market Cap575.699M
  • Shares Out46.80M
  • 10 Day Average Volume1.98M
  • Dividend-
  • Dividend Yield-
  • Beta2.50
  • YTD % Change-44.76

KEY STATS

  • Open12.51
  • Day High13.10
  • Day Low12.18
  • Prev Close12.41
  • 52 Week High26.35
  • 52 Week High Date02/08/24
  • 52 Week Low9.02
  • 52 Week Low Date05/30/23
  • Market Cap575.699M
  • Shares Out46.80M
  • 10 Day Average Volume1.98M
  • Dividend-
  • Dividend Yield-
  • Beta2.50
  • YTD % Change-44.76

RATIOS/PROFITABILITY

  • EPS (TTM)-1.65
  • P/E (TTM)-7.44
  • Fwd P/E (NTM)-6.45
  • EBITDA (TTM)-73.234M
  • ROE (TTM)-39.72%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cabaletta Bio Inc

 

Profile

MORE
Cabaletta Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administration for patients with autoimmune diseases. Its Cabaletta Approach to B cell Ablation (CABA) platform encompasses two strategies: Chimeric Antigen Receptor T cells for Autoimmunity (CARTA) and Chimeric AutoAntibody Receptor T...
Steven Nichtberger M.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Anup Marda
Chief Financial Officer
Michael Gerard
General Counsel, Secretary
Address
2929 Arch Street, Suite 600
Philadelphia, PA
19104
United States

Top Peers

SYMBOLLASTCHG%CHG
ALT
Altimmune Inc
6.87-0.20-2.83%
PRME
Prime Medicine Inc
5.17-0.10-1.90%
STTK
Shattuck Labs Inc
11.01+0.15+1.34%
ATXS
Astria Therapeutics Inc
9.28-0.22-2.32%
ALLO
Allogene Therapeutics Inc
3.02+0.10+3.42%